Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Pfizer Creates More Chinese Partnerships

by Lisa M. Jarvis
August 3, 2009 | A version of this story appeared in Volume 87, Issue 31

Pfizer is solidifying its commitment to enhancing biotech collaboration in China. The company will provide $1.5 million over three years to support basic research projects at the Shanghai Institutes for Biological Sciences. In a separate deal, Pfizer joined forces with Fudan University, also in Shanghai, to create a three-year master's degree clinical data management and statistics program. The first students will start class in September. Fudan professors and Pfizer scientists will teach them biostatistics, clinical sciences, how to monitor and report adverse effects of drugs, and clinical project management. The students will work on active projects from Pfizer's drug development portfolio.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.